Navigator Medicines Emerges With $100m, Autoimmune Candidate

Bispecific AB
Navigator raised $100m and licensed a bispecific antibody • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business